Biochemical Reagent
-
BA6942 5-HydroxylansoprazoleSummary: 5-Hydroxylansoprazole (AG1908) is the active metabolite of Lansoprazole in plasma. - BA6943 PumaprazoleSummary: A reversible proton pump antagonist.
- BA6944 FR-167356Summary: FR-167356 is an orally potent and selective vesicular ATPase inhibitor with values of 170, 220, 370, and 1200 nM for osteoclast plasma membranes, macrophage microsomes, renal brush border membranes, and hepatic lysosomal membranes, respectively.
- BA6945 SGLT2-IN-1Summary: SGLT2-IN-1 is an inhibitor of sodium-dependent glucose cotransporter proteins.
- BA6946 MizagliflozinSummary: Mizagliflozin (DSP-3235freebase) is a potent, orally available, selective inhibitor.
- BA6947 LicogliflozinSummary: An inhibitor of sodium-glucose cotransporter protein (and).
- BA6948 KGA-2727Summary: KGA-2727 is a selective, high affinity and orally active inhibitor.
- BA6949 VelagliflozinSummary: Velagliflozin is an orally available sodium-glucose cotransporter protein 2 inhibitor with antidiabetic activity.
- BA6950 EnavogliflozinSummary: Enavogliflozin (DWP-16001) acts as an antidiabetic active molecule.
- BA6951 TianagliflozinSummary: Tianagliflozin is a sodium/glucose cotransporter protein 2 inhibitor.